Free Newsletter!
BioValley.ch
BioValley Region
Home
About Us
News
Events
Databases
Job Market
Culture & Living
Forum
Links
Contact Us
Latest news
Top Viewed
Most Commented News
International News
Free Newsletter!
Related Topics
»
acquisition
»
Agriculture
»
biotech
»
conference
»
agreement
»
breast cancer
»
Patent Disputes
»
pharma
»
Phase III
»
vaccine
Companies
»
Roche
»
Novartis
»
Genzyme
»
Sanofi-aventis
»
Bayer
»
Abbott Laboratories
»
Agilent Technologies
»
Syngenta
»
Alcon
»
Bayer HealthCare
Category: HIV
Latest news
July 28. 2010
Bio-Rad submits premarket approval application to the FDA for its fourth-generation HIV assay
July 27. 2010
Abbott to feature novel tests and new upgrades to testing platforms at American Association for Clinical Chemistry Lab Expo
July 20. 2010
BD Biosciences introduces CD4 testing product that does not require refrigeration
July 20. 2010
Research: Merck AIDS drug as effective as Abbott pills
July 20. 2010
Abbott's PROGRESS study of Kaletra and Isentress compared with a standard HIV regimen meets the pre-specified primary efficacy endpoint
June 22. 2010
FDA approves first-of-its-kind HIV test which can detect HIV Days earlier than current U.S. tests
June 08. 2010
QIAGEN HPV DNA test donation to expand access to cervical cancer screening for women in rural India
June 04. 2010
FDA approves new Roche dual-PCR target HIV-1 test
April 29. 2010
Abbott receives FDA approval for once-daily dosing of Kaletra (lopinavir / ritonavir) for treatment-experienced patients
March 03. 2010
Twenty-five years of HIV blood testing helped to positively transform global health crisis
February 25. 2010
Rate of T cell count drop not found helpful in deciding when to start HIV treatment
February 12. 2010
Abbott receives FDA approval for heat-stable Norvir tablets
January 26. 2010
Abbott submits new HIV test to FDA for expedited review
January 15. 2010
BD Biosciences collaborates with ReaMetrix to develop new, affordable CD4 testing products to help fight HIV/AIDS in developing countries
December 03. 2009
FDA approves use of Roche test to screen source plasma for HIV, hepatitis B virus and hepatitis C virus
December 02. 2009
Boehringer Ingelheim launches MindBodyHAART.com, a comprehensive online resource for the HIV/AIDS community
October 08. 2009
Boehringer Ingelheim: Access to HIV medication
September 22. 2009
Abbott receives FDA approval for first fully automated blood screening test for HIV-1/HIV-2
September 17. 2009
Boehringer: Head-to-head trial demonstrates Viramune’s similar efficacy and more favourable effect on lipid profile compared to Atazanavir/Ritonavir
July 23. 2009
Abbott HIV test demonstrates earlier disease detection
July 20. 2009
Head-to-head trial demonstrates Viramune's similar efficacy and superior effect on lipid profile compared to atazanavir/ritonavir
May 08. 2009
HIV/AIDS Research Network recommends use of Abbott RealTime viral load test for NIH-sponsored clinical trials
March 06. 2009
HIV experts propose new approach to eradicate HIV in latest issue of Science
February 19. 2009
A 454 sequencing study reveals new insights in drug resistance and tropism associated with the new HIV integrase and entry inhibitor therapy classes
February 18. 2009
454 Sequencing identifies early stage HIV drug resistance-- low-level mutations may have significant impact on clinical outcomes
February 11. 2009
Increasing diversity of HIV strains impacts diagnostic test accuracy
January 05. 2009
FDA approves Roche's most comprehensive system to test donated blood for HIV, Hepatitis B & Hepatitis C
December 29. 2008
Researchers successfully used the 454 sequencing system for sensitive detection of HIV tropism
December 15. 2008
New Roche dual target HIV-1 test approved for use in European Union
November 27. 2008
BD Biosciences announces availability of new CD4 technology in Africa
November 13. 2008
Tibotec data presented at ICAAC and HIV9 follow key regulatory approvals for Anti-HIV compounds
September 01. 2008
Abbott fund to build first pediatric HIV/AIDS clinic in Tanzania
August 08. 2008
Abbott study shows investigational heat-stable Norvir® tablet provides similar drug levels to current norvir capsule
August 06. 2008
Abbott's Kaletra tablet dosed once-daily or twice-daily demonstrated similar clinical results across race and gender lines
July 14. 2008
Roche to drop HIV therapy research
July 14. 2008
Roche to drop HIV therapy research
July 10. 2008
Study finds Aids treatment gap is closing
July 10. 2008
Study finds Aids treatment gap is closing
May 20. 2008
Quest Diagnostics chooses Roche's fully automated, Real-Time HIV-1 viral load monitoring test
May 20. 2008
Quest Diagnostics chooses Roche's fully automated, Real-Time HIV-1 viral load monitoring test
August 14. 2007
FDA grants tentative approval for 50th and 51st anti-retroviral drugs under president's AIDS relief plan
August 14. 2007
FDA grants tentative approval for 50th and 51st anti-retroviral drugs under president's AIDS relief plan
July 20. 2007
Researchers find three genes resistant to HIV
July 20. 2007
Researchers find three genes resistant to HIV
May 23. 2007
European researchers, regulators, the pharmaceutical industry and activists demand better treatment for people with hepatitis C and HIV
February 17. 2006
The Tropical Institute's quest for an HIV/Aid cure
January 12. 2006
Roche offers help to local manufacturers to produce HIV medicine for sub-Saharan Africa and Least Developed Countries
Events
» Sep. 8
Restriction of the developmental potential in intermediate neural progenitors during Drosophila neur...
» Sep. 8
The TOR signaling network: lessons from budding yeast.
» Sep. 9
AK PSM e.V.: Dr. med. Andrea Kuhnert, Dr. med. Peter Posch, Benita Seiberling: Zusatzweiterbildung P...
» Sep. 10
Dr. med. Charlotte Wirl aus Wien, AK PSM e.V.: Aufbaukurs, Medizinische Hypnotherapie Teil 2
more events